Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1211347.RA-zK7PH0KrtpafWQjLZTomVFS-w4wrmbLPUUQSqm4vAo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1211347.RA-zK7PH0KrtpafWQjLZTomVFS-w4wrmbLPUUQSqm4vAo130_assertion type Assertion NP1211347.RA-zK7PH0KrtpafWQjLZTomVFS-w4wrmbLPUUQSqm4vAo130_head.
- NP1211347.RA-zK7PH0KrtpafWQjLZTomVFS-w4wrmbLPUUQSqm4vAo130_assertion description "[We also observed enhanced expression of IRF3 (64 � 6.36 versus 36.1 � 5.57, P = 0.004) and IRF5 (40 � 5.25 versus 22.5 � 2.6%, P = 0.010) restricted to this circulating pDC subset from SLE patients versus healthy controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211347.RA-zK7PH0KrtpafWQjLZTomVFS-w4wrmbLPUUQSqm4vAo130_provenance.
- NP1211347.RA-zK7PH0KrtpafWQjLZTomVFS-w4wrmbLPUUQSqm4vAo130_assertion evidence source_evidence_literature NP1211347.RA-zK7PH0KrtpafWQjLZTomVFS-w4wrmbLPUUQSqm4vAo130_provenance.
- NP1211347.RA-zK7PH0KrtpafWQjLZTomVFS-w4wrmbLPUUQSqm4vAo130_assertion SIO_000772 25130328 NP1211347.RA-zK7PH0KrtpafWQjLZTomVFS-w4wrmbLPUUQSqm4vAo130_provenance.
- NP1211347.RA-zK7PH0KrtpafWQjLZTomVFS-w4wrmbLPUUQSqm4vAo130_assertion wasDerivedFrom befree-2016 NP1211347.RA-zK7PH0KrtpafWQjLZTomVFS-w4wrmbLPUUQSqm4vAo130_provenance.
- NP1211347.RA-zK7PH0KrtpafWQjLZTomVFS-w4wrmbLPUUQSqm4vAo130_assertion wasGeneratedBy ECO_0000203 NP1211347.RA-zK7PH0KrtpafWQjLZTomVFS-w4wrmbLPUUQSqm4vAo130_provenance.